The PE Ratio as of November 2024 (TTM) for Adaptive Biotechnologies Corporation (ADPT) is -3.50

According to Adaptive Biotechnologies Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -3.50. This represents a change of 2.19% compared to the average of -3.43 of the last 4 quarters.

Adaptive Biotechnologies Corporation (ADPT) Historical PE Ratio (quarterly & annually)

How has ADPT PE Ratio performed in the past?

The mean historical PE Ratio of Adaptive Biotechnologies Corporation over the last ten years is -44.48. The current -3.50 PE Ratio has changed 686.85% with respect to the historical average. Over the past ten years (40 quarters), ADPT's PE Ratio was at its highest in in the March 2024 quarter at -2.39. The PE Ratio was at its lowest in in the September 2018 quarter at -128.65.

Adaptive Biotechnologies Corporation (ADPT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Adaptive Biotechnologies Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adaptive Biotechnologies Corporation (ADPT) Average PE Ratio

How has ADPT PE Ratio performed in the past?

The current PE Ratio of Adaptive Biotechnologies Corporation (ADPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adaptive Biotechnologies Corporation (ADPT) PE Ratio vs. Peers

How is ADPT’s PE Ratio compared to its peers?

Adaptive Biotechnologies Corporation’s PE Ratio is less than Verve Therapeutics, Inc. (-2.07), greater than Beam Therapeutics Inc. (-14.38), less than Caribou Biosciences, Inc. (-1.23), less than Sana Biotechnology, Inc. (-2.01), greater than VectivBio Holding AG (-7.94), less than Kinnate Biopharma Inc. (-1.57), less than Royalty Pharma plc (10.33), less than Ikena Oncology, Inc. (-1.38), less than CohBar, Inc. (-0.12), less than Hepion Pharmaceuticals, Inc. (-0.20), less than Rain Therapeutics Inc. (-1.51), less than Krystal Biotech, Inc. (104.40), less than AVROBIO, Inc. (2.07), less than Enveric Biosciences, Inc. (-0.29), less than Elevation Oncology, Inc. (-0.85), greater than Zura Bio Limited (-5.60), greater than Reneo Pharmaceuticals, Inc. (-10.76), greater than Legend Biotech Corporation (-21.42), less than Vir Biotechnology, Inc. (-1.82), greater than Apellis Pharmaceuticals, Inc. (-15.24),

Build a custom stock screener for Adaptive Biotechnologies Corporation (ADPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adaptive Biotechnologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adaptive Biotechnologies Corporation (ADPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adaptive Biotechnologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.